Management of neuronopathic Gaucher disease: a European consensus.
Vellodi
A
A
Metabolic Unit, Great Ormond Street Hospital for Children, London, UK. Ashok.Vellodi@gosh-tr.nthames.nhs.uk
Bembi
B
B
de Villemeur
T B
TB
Collin-Histed
T
T
Erikson
A
A
Mengel
E
E
Rolfs
A
A
Tylki-Szymanska
A
A
D003376:Counseling; D005060:Europe; D005190:Family; D005776:Gaucher Disease / Q000145:classification / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D005962:Glucosylceramidase / Q000627:therapeutic use; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D005962:Glucosylceramidase; C090568:imiglucerase